Article
Treatment of sarcoidosis with cutaneous involvement with tofacitinib
2021-07-05
Abstract excerpt
Sarcoidosis is an idiopathic inflammatory disorder that is commonly treated with glucocorticoids and there are no approved steroid-sparing medications. There is emerging evidence that Janus kinase (JAK) inhibitors, which inhibit JAK-dependent cytokine activity, may hold promise in sarcoidosis. In this open-label trial, 10 patients with recalcitrant sarcoidosis with cutaneous involvement were treated with tofacitin...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d1f4c64c-bb2e-58d2-a916-1338f04cdc51
- DOI
- 10.1101/2021.07.01.21259700
